Innate inflammation in Parkinson's disease
- PMID: 22951445
- PMCID: PMC3426823
- DOI: 10.1101/cshperspect.a009373
Innate inflammation in Parkinson's disease
Abstract
The resident macrophages of the brain--the microglia--are morphologically activated during the progression of Parkinson's disease. Observational studies in human postmortem material and studies in animal models seek to define the contribution that this innate immune response might make to the pathogenesis and rate of progression of Parkinson's disease. We review here some of the key conceptual issues that need to be considered when performing these studies. We highlight the fact that most postmortem studies have not given due consideration to common comorbidities present in patients with Parkinson's disease and also the limitations of attempting to extrapolate from animal models to a chronic progressive neurodegenerative disease in humans that lasts for many years.
References
-
- Aerts MB, Esselink RA, Abdo WF, Bloem BR, Verbeek MM 2011. CSF α-synuclein does not differentiate between parkinsonian disorders. Neurobiol Aging 33: 430.e1–430.e3 - PubMed
-
- Banati RB, Daniel SE, Blunt SB 1998. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson’s disease. Mov Disord 13: 221–27 - PubMed
-
- Barclay AN, Brown MH 2006. The SIRP family of receptors and immune regulation. Nat Rev Immunol 6: 457–464 - PubMed
-
- Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E 2003. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24: 197–211 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical